BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

110 related articles for article (PubMed ID: 12181640)

  • 1. Linkage and association analyses of the osteoprotegerin gene locus with human osteoporosis.
    Ohmori H; Makita Y; Funamizu M; Hirooka K; Hosoi T; Orimo H; Suzuki T; Ikari K; Nakajima T; Inoue I; Hata A
    J Hum Genet; 2002; 47(8):400-6. PubMed ID: 12181640
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Association of the osteoprotegerin gene polymorphisms with bone mineral density in postmenopausal women.
    Arko B; Prezelj J; Kocijancic A; Komel R; Marc J
    Maturitas; 2005 Jul; 51(3):270-9. PubMed ID: 15978970
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Investigation of the genetic influence of the OPG, VDR (Fok1), and COLIA1 Sp1 polymorphisms on BMD in the Irish population.
    Wynne F; Drummond F; O'Sullivan K; Daly M; Shanahan F; Molloy MG; Quane KA
    Calcif Tissue Int; 2002 Jul; 71(1):26-35. PubMed ID: 12073153
    [TBL] [Abstract][Full Text] [Related]  

  • 4. TNFRSF11B gene variants and bone mineral density in postmenopausal women in Malta.
    Vidal C; Brincat M; Xuereb Anastasi A
    Maturitas; 2006 Mar; 53(4):386-95. PubMed ID: 16343827
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Genetic polymorphisms of OPG, RANK, and ESR1 and bone mineral density in Korean postmenopausal women.
    Choi JY; Shin A; Park SK; Chung HW; Cho SI; Shin CS; Kim H; Lee KM; Lee KH; Kang C; Cho DY; Kang D
    Calcif Tissue Int; 2005 Sep; 77(3):152-9. PubMed ID: 16151677
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The relationship between four single nucleotide polymorphisms in the promoter region of the osteoprotegerin gene and aortic calcification or coronary artery disease in Koreans.
    Rhee EJ; Oh KW; Jung CH; Lee WY; Oh ES; Yun EJ; Baek KH; Kang MI; Kim SW
    Clin Endocrinol (Oxf); 2006 Jun; 64(6):689-97. PubMed ID: 16712673
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Polymorphisms in the osteoprotegerin gene are associated with osteoporotic fractures.
    Langdahl BL; Carstens M; Stenkjaer L; Eriksen EF
    J Bone Miner Res; 2002 Jul; 17(7):1245-55. PubMed ID: 12096838
    [TBL] [Abstract][Full Text] [Related]  

  • 8. TNFRSF11B gene polymorphisms 1181G > C and 245T > G as well as haplotype CT influence bone mineral density in postmenopausal women.
    Mencej-Bedrač S; Preželj J; Marc J
    Maturitas; 2011 Jul; 69(3):263-7. PubMed ID: 21411255
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Single nucleotide polymorphisms in the human gene for osteoprotegerin are not related to bone mineral density or fracture in elderly women.
    Brändström H; Gerdhem P; Stiger F; Obrant KJ; Melhus H; Ljunggren O; Kindmark A; Akesson K
    Calcif Tissue Int; 2004 Jan; 74(1):18-24. PubMed ID: 14508625
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Association between osteoprotegerin (OPG), receptor activator of nuclear factor-kappaB (RANK), and RANK ligand (RANKL) gene polymorphisms and circulating OPG, soluble RANKL levels, and bone mineral density in Korean postmenopausal women.
    Kim JG; Kim JH; Kim JY; Ku SY; Jee BC; Suh CS; Kim SH; Choi YM
    Menopause; 2007; 14(5):913-8. PubMed ID: 17667143
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Association of polymorphisms of the osteoprotegerin gene with bone mineral density in Japanese women but not men.
    Yamada Y; Ando F; Niino N; Shimokata H
    Mol Genet Metab; 2003 Nov; 80(3):344-9. PubMed ID: 14680982
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Effect of osteoprotegerin gene polymorphism on bone mass in postmenopausal women].
    Cheng Q; Zhu HM; Miao YX; Zhu XY; Chen XP; Zhang XM
    Zhonghua Yi Xue Za Zhi; 2004 Feb; 84(4):274-7. PubMed ID: 15059506
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Sequence variations in the osteoprotegerin gene promoter in patients with postmenopausal osteoporosis.
    Arko B; Prezelj J; Komel R; Kocijancic A; Hudler P; Marc J
    J Clin Endocrinol Metab; 2002 Sep; 87(9):4080-4. PubMed ID: 12213850
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Tumour necrosis factor superfamily member 11 gene promoter polymorphisms modulate promoter activity and influence bone mineral density in postmenopausal women with osteoporosis.
    Mencej S; Albagha OM; Prezelj J; Kocjan T; Marc J
    J Mol Endocrinol; 2008 Jun; 40(6):273-9. PubMed ID: 18502820
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The effects of C161-->T polymorphisms in exon 6 of peroxisome proliferator-activated receptor-gamma gene on bone mineral metabolism and serum osteoprotegerin levels in healthy middle-aged women.
    Rhee EJ; Oh KW; Lee WY; Kim SY; Oh ES; Baek KH; Kang MI; Kim SW
    Am J Obstet Gynecol; 2005 Apr; 192(4):1087-93. PubMed ID: 15846185
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The combinations of polymorphisms in vitamin D receptor, osteoprotegerin and tumour necrosis factor superfamily member 11 genes are associated with bone mineral density.
    Mencej-Bedrac S; Prezelj J; Kocjan T; Teskac K; Ostanek B; Smelcer M; Marc J
    J Mol Endocrinol; 2009 Mar; 42(3):239-47. PubMed ID: 19131500
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A single nucleotide polymorphism in the promoter region of the osteoprotegerin gene is related to intima-media thickness of the carotid artery in hypertensive patients. The Swedish Irbesartan Left Ventricular Hypertrophy Investigation vs Atenolol (SILVHIA).
    Brändström H; Stiger F; Kahan T; Melhus H; Nyström F; öHman KP; Malmqvist K; Lind L; Kindmark A
    Blood Press; 2004; 13(3):152-7. PubMed ID: 15223723
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Evaluation of RANK/RANKL/OPG gene polymorphisms in aggressive periodontitis.
    Soedarsono N; Rabello D; Kamei H; Fuma D; Ishihara Y; Suzuki M; Noguchi T; Sakaki Y; Yamaguchi A; Kojima T
    J Periodontal Res; 2006 Oct; 41(5):397-404. PubMed ID: 16953816
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Novel and selective small molecule stimulators of osteoprotegerin expression inhibit bone resorption.
    Onyia JE; Galvin RJ; Ma YL; Halladay DL; Miles RR; Yang X; Fuson T; Cain RL; Zeng QQ; Chandrasekhar S; Emkey R; Xu Y; Thirunavukkarasu K; Bryant HU; Martin TJ
    J Pharmacol Exp Ther; 2004 Apr; 309(1):369-79. PubMed ID: 14718597
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Gene therapy with human recombinant osteoprotegerin reverses established osteopenia in ovariectomized mice.
    Kostenuik PJ; Bolon B; Morony S; Daris M; Geng Z; Carter C; Sheng J
    Bone; 2004 Apr; 34(4):656-64. PubMed ID: 15050896
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.